Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice

PLoS One. 2011;6(7):e21878. doi: 10.1371/journal.pone.0021878. Epub 2011 Jul 15.

Abstract

IL-11 is multifunctional cytokine whose physiological role in the lungs during pulmonary tuberculosis (TB) is poorly understood. Here, using in vivo administration of specific antibodies against IL-11, we demonstrate for the first time that blocking IL-11 diminishes histopathology and neutrophilic infiltration of the lung tissue in TB-infected genetically susceptible mice. Antibody treatment decreased the pulmonary levels of IL-11 and other key inflammatory cytokines not belonging to the Th1 axis, and down-regulated IL-11 mRNA expression. This suggests the existence of a positive feedback loop at the transcriptional level, which is further supported by up-regulation of IL-11 mRNA expression in the presence of rIL-11 in in vitro cultures of lung cells. These findings imply a pathogenic role for IL-11 during the early phase of Mycobacterium tuberculosis-triggered disease in a genetically susceptible host.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / administration & dosage
  • Antibodies / therapeutic use
  • Autocrine Communication
  • Female
  • Genetic Predisposition to Disease*
  • Interleukin-11 / biosynthesis
  • Interleukin-11 / genetics
  • Interleukin-11 / immunology*
  • Lung / immunology
  • Lung / microbiology
  • Lung / pathology
  • Mice
  • Mycobacterium tuberculosis / immunology*
  • Pneumonia / complications
  • Pneumonia / drug therapy
  • Pneumonia / immunology*
  • Pneumonia / microbiology*
  • Transcription, Genetic
  • Tuberculosis, Pulmonary / complications
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / immunology*
  • Tuberculosis, Pulmonary / microbiology*

Substances

  • Antibodies
  • Interleukin-11